5 years ago

Statin prescribing for prevention of cardiovascular disease amongst people with severe mental illness: Cohort study in UK primary care

Severe mental illness (SMI) is associated with excess cardiovascular disease (CVD) morbidity, but little is known on provision of preventative interventions. We investigated statin initiation for primary CVD prevention in individuals with and without SMI. Methods We used primary care data from The Health Improvement Network from 2006 to 2015 for UK patients aged 30–99years with no pre-existing CVD conditions and selected individuals with schizophrenia (n =13,252) or bipolar disorder (n =11,994). In addition, we identified samples of individuals without schizophrenia (n =66,060) and bipolar disorder (n =59,765), but with similar age and gender distribution. Missing data on CVD covariates were estimated using multiple imputation. Statin prescribing differences between individuals with and without SMI were investigated using multivariable Poisson regression models. Results Initiation of statin prescribing was between 2 and 3 fold higher in people aged 30–59years with SMI than in those without after adjusting for CVD covariates. The rates in those aged 60–74years with SMI were similar or slightly higher relative to those without SMI. The incidence rate ratio (IRR) was 1.15 (95% CI 1.03–1.28) for bipolar disorder and 1.00 (0.91–1.11) for schizophrenia. The rate of statin prescribing was lower (IRR 0.81 (0.66–0.98)) amongst the oldest (aged 75+years) with schizophrenia relative to those without schizophrenia. Conclusions Despite higher rates of new statin prescriptions to younger individuals with SMI relative to individuals without SMI, there was evidence of lower rates of statin initiation for older individuals with schizophrenia, and this group may benefit from additional measures to prevent CVD.

Publisher URL: www.sciencedirect.com/science

DOI: S0920996417303031

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.